SG Americas Securities’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

SG Americas Securities’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-38,785	Closed	-$1.8M	–	3323
2023 Q2	$1.8M	Buy	38,785 +29,072	+299%	+$1M	0.01%	793
2023 Q1	$278K	Sell	9,713 -6,890	-41%	-$204K	﹤0.01%	2178
2022 Q4	$518K	Buy	+16,603	New	+$541K	0.01%	1503
2022 Q3	–	Sell	-8,429	Closed	-$131K	–	3670
2022 Q2	$131K	Buy	+8,429	New	+$145K	﹤0.01%	2953

SG Americas Securities's DICE Position: Q3 2023 in Review

SG Americas Securities sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 38,785 shares — an estimated $1.8M sold.

SG Americas Securities first reported a position in DICE in Q2 2022 and held it in 4 quarters. The position peaked at $1.8M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

SG Americas Securities reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
SG Americas Securities sold 38,785 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.8M.
SG Americas Securities first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
SG Americas Securities's DICE Therapeutics, Inc. Common Stock position peaked at $1.8M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on SG Americas Securities's 13F filing for Q3 2023, filed 13 Oct 2023.